Sameera Aljohani
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 14
- Influenza Virus Research Studies 4
- Mycobacterium research and diagnosis 4
- Respiratory viral infections research 4
-
- SARS-CoV-2 and COVID-19 Research 6
- SARS-CoV-2 detection and testing 4
- Antifungal resistance and susceptibility 3
- Co-authors
- Hanan H. Balkhy (7 shared papers)Hamdan Al‐Jahdali (3 shared papers)Salim Baharoon (2 shared papers)Yaseen M. Arabi (4 shared papers)Ali H. Hajeer (3 shared papers)Mohammed Al Balwi (2 shared papers)Khaled O. Alsaad (1 shared paper)Giamal Gmati (1 shared paper)
- Journals
- Journal of Infection and Public Health (4 papers)PLoS neglected tropical diseases (3 papers)Pathogens (2 papers)BMC Infectious Diseases (2 papers)BioMed Research International (1 paper)
- Partner nations
- Saudi ArabiaUnited StatesSwitzerland
In The Last Decade
Sameera Aljohani
32 papers receiving 732 citations
Peers
Comparison fields: 5 of 94
- Applied Microbiology and Biotechnology 41
- Molecular Medicine 110
- Infectious Diseases 300
- Endocrinology 31
- Modeling and Simulation 26
Countries citing papers authored by Sameera Aljohani
This map shows the geographic impact of Sameera Aljohani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameera Aljohani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameera Aljohani more than expected).
Fields of papers citing papers by Sameera Aljohani
This network shows the impact of papers produced by Sameera Aljohani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameera Aljohani. The network helps show where Sameera Aljohani may publish in the future.
Co-authors
The 25 scholars most cited alongside Sameera Aljohani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 219 | |
| 2 | 2020 | 84 | |
| 3 | 2017 | 62 | |
| 4 | 2018 | 52 | |
| 5 | 2020 | 34 | |
| 6 | 2019 | 27 | |
| 7 | 2022 | 26 | |
| 8 | 2017 | 22 | |
| 9 | 2019 | 22 | |
| 10 | 2017 | 22 | |
| 11 | 2013 | 20 | |
| 12 | 2017 | 19 | |
| 13 | 2020 | 16 | |
| 14 | 2019 | 14 | |
| 15 | 2014 | 13 | |
| 16 | 2022 | 13 | |
| 17 | 2018 | 12 | |
| 18 | 2021 | 10 | |
| 19 | 2018 | 9 | |
| 20 | 2022 | 8 |
About Sameera Aljohani
Sameera Aljohani is a scholar working on Epidemiology, Infectious Diseases, Molecular Medicine, Molecular Biology and Endocrinology, having authored 35 papers that have together received 750 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Influenza Virus Research Studies (4 papers), SARS-CoV-2 detection and testing (4 papers), Mycobacterium research and diagnosis (4 papers), Respiratory viral infections research (4 papers), Antifungal resistance and susceptibility (3 papers) and Biosensors and Analytical Detection (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (41 citations), Molecular Medicine (110 citations), Infectious Diseases (300 citations), Endocrinology (31 citations) and Modeling and Simulation (26 citations). Sameera Aljohani has collaborated with scholars based in Saudi Arabia, United States and Switzerland. Frequent co-authors include Hanan H. Balkhy, Hamdan Al‐Jahdali, Salim Baharoon, Yaseen M. Arabi, Ali H. Hajeer, Mohammed Al Balwi, Khaled O. Alsaad, Giamal Gmati, Sami Alsolamy and Saleh Eifan. Their work appears in journals such as Journal of Infection and Public Health, PLoS neglected tropical diseases, Pathogens, BMC Infectious Diseases and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.